137 related articles for article (PubMed ID: 2176516)
1. Effect of hypo- and hyperthyroidism on binding of [3H]-nitrendipine to myocardial and brain membranes.
Kosinski C; Gross G; Hanft G
Br J Clin Pharmacol; 1990; 30 Suppl 1(Suppl 1):128S-130S. PubMed ID: 2176516
[TBL] [Abstract][Full Text] [Related]
2. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of [3H]nitrendipine binding to brain and cardiac membranes by bacitracin.
Smith JD; Bolger GT
Can J Physiol Pharmacol; 1989 Dec; 67(12):1591-5. PubMed ID: 2560678
[TBL] [Abstract][Full Text] [Related]
4. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
[TBL] [Abstract][Full Text] [Related]
5. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
Garthoff B; Bellemann P
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S36-9. PubMed ID: 2455136
[TBL] [Abstract][Full Text] [Related]
6. Novel interactions of cations with dihydropyridine calcium antagonist binding sites in brain.
Bolger GT; Skolnick P
Br J Pharmacol; 1986 Aug; 88(4):857-66. PubMed ID: 3017494
[TBL] [Abstract][Full Text] [Related]
7. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload.
Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T
Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404
[TBL] [Abstract][Full Text] [Related]
8. Increased [3H]nitrendipine binding sites in rat heart during adult maturation and aging.
Navaratnam S; Khatter JC
Biochem Pharmacol; 1991 Feb; 41(4):593-600. PubMed ID: 1847636
[TBL] [Abstract][Full Text] [Related]
9. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy.
Lee SL; Ostadalova I; Kolar F; Dhalla NS
Mol Cell Biochem; 1992 Feb; 109(2):173-9. PubMed ID: 1320733
[TBL] [Abstract][Full Text] [Related]
10. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
Ballesta JJ; Garcia AG; Gutierrez LM; Hidalgo MJ; Palmero M; Reig JA; Viniegra S
Br J Pharmacol; 1990 Sep; 101(1):21-6. PubMed ID: 1704272
[TBL] [Abstract][Full Text] [Related]
11. Halothane decreases calcium channel antagonist binding to cardiac membranes.
Blanck TJ; Runge S; Stevenson RL
Anesth Analg; 1988 Nov; 67(11):1032-5. PubMed ID: 2847594
[TBL] [Abstract][Full Text] [Related]
12. Nitrendipine binding in congestive heart failure due to myocardial infarction.
Dixon IM; Lee SL; Dhalla NS
Circ Res; 1990 Mar; 66(3):782-8. PubMed ID: 2155068
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
Rasmussen RP; Minobe W; Bristow MR
Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
[TBL] [Abstract][Full Text] [Related]
14. [3H]-nitrendipine binding in membranes obtained from hypoxic and reoxygenated heart.
Matucci R; Bennardini F; Sciammarella ML; Baccaro C; Stendardi I; Franconi F; Giotti A
Biochem Pharmacol; 1987 Apr; 36(7):1059-62. PubMed ID: 3032202
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
16. Effect of membrane depolarization on binding of [3H]nitrendipine to rat cardiac myocytes.
Green FJ; Farmer BB; Wiseman GL; Jose MJ; Watanabe AM
Circ Res; 1985 Apr; 56(4):576-85. PubMed ID: 2983904
[TBL] [Abstract][Full Text] [Related]
17. Regional and subcellular distribution of [3H]nitrendipine binding sites in SHR and WKY rats.
Ross D; Monis N
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S94-7. PubMed ID: 2468884
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
19. Comparison of [3H]nitrendipine binding to heart membranes of normotensive and spontaneously hypertensive rats.
Chatelain P; Demol D; Roba J
J Cardiovasc Pharmacol; 1984; 6(2):220-3. PubMed ID: 6200707
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity.
Schoemaker H; Hicks PE; Langer SZ
J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
